同種造血幹細胞移植後のcGVHDに対するリツキシマブベースの初回治療：第2相試験の結果

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high‐risk aggressive non‐Hodgkin's lymphoma2003 · 76 citations
2. 2Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation2010 · 1,483 citations
3. 3Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease2001 · 138 citations
4. 4The Role of Cardiovascular T2*MRI and Tissue Doppler Measurement in Assesment of Cardiac Status in β-Thalassemia Major2014 · 32 citations
5. 5Regulatory B Cells: Origin, Phenotype, and Function2015 · 1,419 citations